my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
18-05-2006: Charles River Laboratories, Inc. and genOway announced the establishment of a three-year North American collaboration. This strategic alliance will provide pharmaceutical, biotechnology, and academic researchers with innovative research models to better understand human diseases. genOway holds intellectual property rights to multiple processes for the development of research models and offers a full range of solutions for both gene expression and gene inactivation.
"Charles River Laboratories is delighted to expand our relationship with genOway by adding to our successful European collaboration with this North American agreement." said William Barbo, Corporate Vice President, Research Model Services, Charles River Laboratories. "With this collaboration, we can promote genOway's solutions and further assist our clients in the most efficient pursuit of their research goals."
Watchlist
This is where you can add this news to your personal favourites
Protagen and Charles River Form Strategic Partnership
Protagen AG and Charles River Laboratories International, Inc. are announce a strategic Marketing & Sales alliance. For Charles River Biopharmaceutical Services (BPS) the fast-growing demand for biopharmaceuticals testing requires an expert partner with a broad range of services. Charles R ... more
Charles River Laboratories Announces Plan to Construct New Preclinical Services Facility in Quebec
Charles River Laboratories International, Inc. announced that it intends to build a new facility in Sherbrooke, Quebec, to support the company's expanding Preclinical Services business. Located in the newly constructed Sherbrooke Biomedical Park, Charles River's newest facility shall provid ... more
Charles River Establishes a New Facility in Korea to Provide Endosafe Products and Services
Charles River Laboratories announced the establishment of Charles River Endosafe Korea. Effective May 1, 2007, Endosafe®products will be sold and supported directly by the new, wholly owned Korean operation. The focus of Endosafe Korea's scientific staff will be to promote and ensure regula ... more
Charles River Laboratories International, Inc.
Charles River is the world's leading supplier of endotoxin detection products. As a global provider of rapid microbiological product solutions, our goal is to provide superior product quality and consistency to the scientific community. more
Charles River Laboratories, Inc.
From our headquarters near Boston, MA, Charles River Laboratories' 7,500 employees serve clients as global providers of solutions that advance the drug discovery and development process. Our leading-edge products and services enable our clients to bring drugs to market faster and more ef ... more
Charles River Laboratories Clinical Services GmbH
From our headquarters near Boston, MA, Charles River Laboratories' 7,500 employees serve clients as global providers of solutions that advance the drug discovery and development process. Our leading-edge products and services enable our clients to bring drugs to market faster and more eff ... more
genOway reported an agreement with the Griffith University on a eight-months research partnership with its Eskitis Institute for Cell and Molecular Therapies focusing on autologous olfactory adult stem cells. This research program is coupled with a world wide exclusive license to genOway fo ... more
Cellectis and Genoway close their disagreement
Cellectis and Genoway indicate that the sublicense agreement dated September 7, 2001, relating to the patents and patent applications belonging to the pool WO90/11354 has been terminated as of December 30, 2008. Cellectis and Genoway have agreed on the consequences of such termination of t ... more
genOway and Boehringer Ingelheim reinforce their collaboration
genOway reports a collaboration with Boehringer Ingelheim for the development of experimental research models. This collaboration has been recently reinforced and now includes several innovative technological solutions developed by genOway to create more powerful research models. genOway u ... more
The development of a new drug costs roughly 800 M.USD. This huge investment has to cover both the development of the drug itself and the cost of unfruitful work. Dead-ends can represent up to 80% of the total cost of a successful drug. Major challenges in the drug development process are (1 ... more
The development of a new drug costs roughly 800 M.USD. This huge investment has to cover both the development of the drug itself and the cost of unfruitful work. Dead-ends can represent up to 80% of the total cost of a successful drug. Major challenges in the drug development process are (1 ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
